KB Visions, Inc. articles and information in the news media

KB Visions, Inc. is the exclusive, worldwide licensee of the patents and related technology for veterinary applications of ophthalmic cyclosporine.

Home

About Us

In the News

Ophthalmic Cyclosporine Patents

Ophthalmic Cyclosporine Publications

KB Visions, Inc. Notification

Frequently Asked Questions

Licensed Compounding Pharmacies

Contact Us

Articles and issues in the news media relating to KB Visions, Inc.

Allergan announces FDA approval for Restasis®

DVM New Magazine, Sept. 1, 2002

KB Visions, Inc., a Victim of Schering-Plough's Regulatory Woes, Initiates Legal Action Against Patent Violators for Triple Damages, Aug. 8, 2002

Home | About Us | Licensed Pharmacies | Ophthalmic Cyclosporine Patents | Ophthalmic Cyclosporine Publications
In the News | KB Visions' Notification | FAQs | Links | Contact Us

KB Visions, Inc.
6787 Riverside Dr. NW
Atlanta, Georgia 30328
©2002 KB Visions, Inc. All rights reserved.